MEDPAL AI is trading at £3.60 (-5.26%) after no clear company-specific catalyst was identified for August 18, 2026.

  • No new company announcement was listed for August 18, 2026; the latest RNS remained the August 11 GLP-1 authorisation update.
  • Healthcare shares broadly weakened on growth concerns, but evidence does not establish a direct link to MEDPAL AI.
  • The decline appears to continue recent weakness following the August 10–17 rally and pullback.